National Lockdown update:  Our Hospital is still fully open for appointments and admissions, however visitors are not permitted. To keep you safe we have strict measures in place, read more about these here. To make an outpatient appointment, please call: 0207 806 4060.

Do NOT visit the Hospital if you have any COVID-19 symptoms. Please visit the Track and Trace website.


Dr Anupam Bhattacharjee

Dr Anupam Bhattacharjee

Dr Anupam Bhattacharjee

Qualifications: BSc, PhD, MBBS, MRCP(UK)

MRCP (UK) (Neurology)

Expertise: General Neurology, Neuromuscular disease including peripheral nerve disease, Headache and neuropathic pain, Neuro-inflammatory and neuro-immunological disease including MS, Blackouts, dizziness and balance disorders, Parkinson’s Disease and other movement disorders

NHS: Royal Free Hospital (London)

Contact info and availability

Telephone Number: 020 7806 4060

Email Address:

Make an Enquiry

Consultant Biography

Dr Bhattacharjee studied at Guy’s and St. Thomas’ Hospitals (later Kings College) where he achieved a 1st Class in Physiology and went onto successfully complete an MB/PhD programme funded by the Migraine Trust and qualified with distinction. He did all his post-graduate general medical training at St. Thomas’, Hammersmith, Royal Brompton, National (Queen Square) and Kings College Hospitals. He completed his Specialist Registrar training in Neurology between the Royal Free Hospital and the National Hospital (Queen Square) where he did a locum consultant post in Neuromuscular disease prior to completing his training. He is a Consultant Neurologist working between the Lister and Royal Free Hospitals. He has a large general neurology practice at Lister and runs a specialist service in neuromuscular and peripheral nerve diseases at the Royal Free Hospital. He is a member of the Royal Free IVIg committee and has helped develop a large plasma exchange service treating patients with various neuro-immunological disorders. He presents work regularly at national and international conferences and has served in an advisory capacity to pharmaceutical companies involved in the treatment of neuro-immunological diseases including MS and CIDP.